First DataBank divests Medi-Span
Executive Summary
Hearst subsidiary First DataBank sells Medi-Span business to Wolters Kluwer's Facts and Comparisons as part of a proposed settlement with the Federal Trade Commission Nov. 9. Under the settlement, First DataBank customers can terminate their contracts for National Drug Data File products. In April, FTC filed a complaint against Hearst in D.C. federal court alleging that Hearst had monopolized the integrated drug information database market via its acquisition of Medi-Span (1"The Pink Sheet" April 9, p. 6)...
You may also be interested in...
First DataBank Must Create Integratable Data Files Competitor, FTC Says
First DataBank would be required to set up a competitor in the integratable drug data file market under an April 4 FTC complaint regarding the 1998 acquisition of Medi-Span by Hearst, which also owns First DataBank.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.